Table 4 Most frequent adverse events up to week 4 (safety population)^*

Any AE

51 (82.3%)

50 (76.9%)

0.456

CMV infection

51 (82.3%)

50 (76.9%)

0.456

CMV disease

6 (9.7%)

6 (9.2%)

0.931

EBV infection

2 (3.2%)

9 (13.8%)

0.033

EBV disease

1 (1.6%)

5 (7.7%)

0.102

HHV-6 infection

5 (8.1%)

4 (6.2%)

0.675

Platelets decreased^a

6 (9.7%)

5 (7.7%)

0.691

Neutropenia^a

7 (11.3%)

11 (16.9%)

0.363

Anaemia^a

5 (8.1%)

2 (3.1%)

0.218

Sepsis

4 (6.5%)

2 (3.1%)

0.370

Bacterial pneumonia

1 (1.6%)

4 (6.2%)

0.188

Fungal infection

1 (1.6%)

1 (1.5%)

0.973

Abdominal or intestinal infection

4 (6.5%)

9 (13.8%)

0.169

Acute kidney injury

4 (6.5%)

4 (6.2%)

0.945